KK
CGON icon

KLP Kapitalforvaltning’s CG Oncology CGON Stock Holding History

KLP Kapitalforvaltning’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$817K Buy
11,500
+2,000
+21% +$131K ﹤0.01% 1248
2026
Q1 		$643K Buy
9,500
+400
+4% +$22.7K ﹤0.01% 1289
2025
Q4 		$378K Buy
9,100
+1,000
+12% +$41.4K ﹤0.01% 1550
2025
Q3 		$326K Hold
8,100
– – ﹤0.01% 1619
2025
Q2 		$211K Hold
8,100
– – ﹤0.01% 1768
2025
Q1 		$198K Buy
8,100
+4,600
+131% +$129K ﹤0.01% 1746
2024
Q4 		$100K Buy
+3,500
New +$120K ﹤0.01% 2086

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KLP Kapitalforvaltning's CGON Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its CG Oncology (CGON) stake by 21% in Q2 2026, buying an estimated $131K and bringing the position to 11,500 shares worth $817K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

KLP Kapitalforvaltning first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • KLP Kapitalforvaltning held 11,500 shares of CG Oncology worth $817K as of Q2 2026.
  • KLP Kapitalforvaltning bought 2,000 CG Oncology shares in Q2 2026, an estimated $131K.
  • CG Oncology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1248 holding.
  • KLP Kapitalforvaltning first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.